18F-Fluoromisonidazole
Tier C — Watch / trade18F-Fluoromisonidazole
Targets：Updating
Indications (approved)：Squamous cell carcinoma, 口咽肿瘤, Glioblastoma, Brain metastases, Head and neck squamous cell carcinoma, Breast cancer, 三阴性乳腺癌, Sarcoma
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| [18F]FMISO-001 | 150196-34-2 | 3-(2-nitro-1H-imidazol-1-yl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propyl 4-methylbenzenesulfonate |
| [18F]FMISO-002 | 753450-86-1 | - |
| 18F-Fluoromisonidazole | 104613-87-8 | - |
Frequently asked questions
What are the approved indications of 18F-Fluoromisonidazole?
Approved indications include: Squamous cell carcinoma, 口咽肿瘤, Glioblastoma, Brain metastases, Head and neck squamous cell carcinoma, Breast cancer, 三阴性乳腺癌, Sarcoma.
When does the 18F-Fluoromisonidazole patent expire?
No public expiry year is available for 18F-Fluoromisonidazole yet; this page updates once verified.
How many synthesis routes are recorded for 18F-Fluoromisonidazole?
1 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy 18F-Fluoromisonidazole intermediates?
All intermediates in 18F-Fluoromisonidazole routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for 18F-Fluoromisonidazole intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01